Appendix Cancer Cases Surge Among Under-50s, Driven by Detection and Classification Changes
Diagnoses of appendix cancer in people under 50 have risen sharply, outpacing many other cancers, largely because more appendectomies and a WHO re-classification have increased detection.
Appendix cancer is becoming more common among adults under 50, with US studies reporting a 71% jump in cases over ten years and UK research documenting a five-fold increase from 1995 to 2016, particularly in the 20-39 age bracket. Although overall incidence stays low at roughly 1.6 per 100,000, the trend worries clinicians because the disease often lacks clear symptoms and is frequently discovered only after it has spread.
The surge is driven by two main factors: a rise in appendectomies that reveal small neuroendocrine tumours (NETs) and a 2000 WHO re-classification that now labels these NETs as cancer rather than benign carcinoids. Early-stage NETs typically need only the appendix removed, but rarer forms such as adenocarcinomas and pseudomyxoma peritonei have also increased, demanding complex surgeries and heated intraperitoneal chemotherapy (HIPEC). Specialists highlight possible environmental contributors, including diet and microbiome changes, while emphasizing that early detection and lifestyle measures may reduce risk.
Why it matters
The growing incidence of appendix cancer in younger adults signals a need for better awareness, early detection and research into underlying causes.
In this story
